Trials / Completed
CompletedNCT02287831
Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Injection for Peripheral Arterial Disease
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of umbilical cord blood mesenchymal stem cells with peripheral arterial disease.
Detailed description
The present study is designed to implant UCB-MSC in patients with CLI, which are resulted from peripheral arterial disease,such as thromboangiitis obliterans, atherosclerosis obliterans and diabetic foot, and to evaluate the safety and efficacy of the implantation procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | umbilical cord mesenchymal stem cells |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-26
- First posted
- 2014-11-11
- Last updated
- 2023-02-08
Source: ClinicalTrials.gov record NCT02287831. Inclusion in this directory is not an endorsement.